Lynx Therapeutics, Affymetrix, Epoch Biosciences, US National Institutes of Health, MWG Biotech, Department of Energy, Integrated Genomics, Beckman Coulter, First Genetic Trust, Expression Analysis | GenomeWeb

Lynx to Help NIMH Study Gene Expression in Human Brains

Lynx Therapeutics has signed a service contract with the National Institute of Mental Health to study gene expression in the brain, the company said last week.

Specifically, researchers at the NIMH’s Genes, Cognition, and Psychosis program will use Lynx’s Massively Parallel Signature Sequencing technology to analyze gene expression in a region of the brain implicated in schizophrenia. Lynx will receive payments for its services on samples provided by NIMH.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.